Comparison of p53 gene mutations in paired primary and metastatic gastric tumor tissues.
10.3346/jkms.1993.8.3.187
- Author:
Joo Hang KIM
1
;
Jung Joo CHOI
;
Sung Hoon NOH
;
Jae Kyung ROH
;
Jin Sik MIN
;
Jung Koo YOUN
;
Nae Chun YOO
;
Ho Yeong LIM
;
David P CARBONE
;
Adi F GAZDAR
;
Kyong Sik LEE
;
Byung Soo KIM
Author Information
1. Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
- Publication Type:Original Article ; Comparative Study ; Research Support, Non-U.S. Gov't
- Keywords:
p53 gene;
Gastric cancer;
Metastasis;
Mutation;
Cancer progression
- MeSH:
Base Sequence;
Chromosome Deletion;
DNA, Complementary/chemistry;
*Genes, p53;
Humans;
Molecular Sequence Data;
Mutation;
Neoplasm Metastasis/*genetics;
Polymorphism, Restriction Fragment Length;
RNA, Messenger/analysis;
Stomach Neoplasms/*genetics/pathology/secondary
- From:Journal of Korean Medical Science
1993;8(3):187-191
- CountryRepublic of Korea
- Language:English
-
Abstract:
Our previous study revealed that mutations of the p53 gene were detected by cDNA sequencing in one of four (25%) primary gastric tumors and in five of six (83%) gastric cancer cell lines. It was of interest that all five cell lines established from metastatic lesions had p53 gene mutations, while the single cell line established from a primary tumor lacked an abnormality. Thus, the current study was initiated to determine the frequency of p53 mutations in 10 pairs of samples from primary gastric carcinomas and their lymph node metastases, in addition to morphologically normal gastric mucosa. In addition, we correlated the findings with other relevant molecular markers including the metastasis associated nm23-H1 gene and loss of heterozygosity (LOH) using multiple polymorphic markers for chromosome 17p and sequencing the entire open reading frame (ORF) of the p53 gene. Five of ten (50%) patients were constitutionally heterozygous for one or more 17p and/or p53 probes (pYNZ 22, BamHI RFLP; pMct35.1, Mspl RFLP; php53cl, Bg/II RFLP), while none had LOH at the 17p and/or p53. A Bg/II RFLP for analysis of possible nm23-H1 somatic allelic deletion revealed no LOH out of four informative cases. One paired sample demonstrated the substitution of valine for isoleucine at codon 41 (GTT to ATT) in both primary gastric tumor and metastasis. Another metastatic sample demonstrated the substitution of proline for threonine at codon 278 (CCT to C/ACT) in addition to a non-mutated codon, while only the wild-type p53 sequence was present in the paired primary gastric tumor tissue.(ABSTRACT TRUNCATED AT 250 WORDS)
